Dragør, Denmark

Steen Jensen

This inventor holds 3 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Ascendis Pharma Endocrinology Division A/s, Ascendis Pharma Endocrinology Division. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steen Jensen. Retrieved from https://idiyas.com/inventor/steen-jensen-n45fcdrs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Steen Jensen

Introduction

Steen Jensen is a notable inventor based in Dragoer, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of growth hormone treatments. With a total of 3 patents, his work has the potential to impact the treatment of growth hormone deficiencies.

Latest Patents

One of his latest patents is for polymeric human growth hormone prodrugs. This invention relates to a polymeric formulation that can be used as a medicament for treating diseases that can be addressed with growth hormone. It also includes methods of application for this prodrug. Another significant patent is for a long-acting growth hormone treatment. This pharmaceutical formulation is designed for treating growth hormone deficiency and involves a bracketed dosage regimen with increasing amounts of growth hormone equivalents.

Career Highlights

Steen Jensen has worked with Ascendis Pharma Endocrinology Division, where he has contributed to advancements in endocrinology. His expertise in pharmaceutical formulations has been instrumental in developing innovative treatments for patients.

Collaborations

Some of his notable coworkers include Harald Rau and Evelyn Exner. Their collaboration has likely contributed to the success of the projects they have worked on together.

Conclusion

Steen Jensen's innovations in the field of growth hormone treatments demonstrate his commitment to improving patient care through scientific advancements. His patents reflect a deep understanding of pharmaceutical formulations and their applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…